Galera Therapeutics Inc
OTC:GRTX

Watchlist Manager
Galera Therapeutics Inc Logo
Galera Therapeutics Inc
OTC:GRTX
Watchlist
Price: 0.023 USD 4.55% Market Closed
Market Cap: 1.7m USD

Operating Margin
Galera Therapeutics Inc

0%
Current
0%
Average
-4.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-14.5m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Galera Therapeutics Inc
Glance View

Market Cap
1.7m USD
Industry
Biotechnology

Galera Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company is headquartered in Malvern, Pennsylvania and currently employs 30 full-time employees. The company went IPO on 2019-11-07. The firm is focused on developing and commercializing a pipeline of therapeutics to transform radiotherapy in cancer. The firm's lead product candidate, avasopasem manganese (GC4419), is a potent and selective small molecule dismutase mimetic, which is developed for the reduction of severe oral mucositis (SOM). The company is also developing a second dismutase mimetic product candidate, GC4711, to increase the anti-cancer efficacy of stereotactic body radiation therapy (SBRT). The company is evaluating GC4419 in a Phase III registrational trial (ROMAN trial) to reduce the incidence and severity of SOM induced by radiotherapy in patients with head and neck cancer (HNC), its lead indication. The firm is also evaluating GC4711 in combination with SBRT in a Phase I/II safety and anti-cancer efficacy trial in non-small cell lung cancer and a Phase IIb trial of GC4711 in combination with SBRT in patients with pancreatic cancer.

GRTX Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-14.5m
/
Revenue
0
What is the Operating Margin of Galera Therapeutics Inc?

Based on Galera Therapeutics Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top